Dear Reader,

As we reach the final issue of *Drugs---Real World Outcomes* for 2017, we wish to reflect on another successful year's achievements, and to thank all those who have contributed their time and effort to guarantee the high quality of our content.

2017 was a successful year for *Drugs---Real World Outcomes*. Over 25 articles have been published; the most popular of these, in terms of downloads from SpringerLink as at September 2017, have been:

[Characterisation of Drug-Related Problems and Associated Factors at a Clinical Pharmacist Service-Naïve Hospital in Northern Sweden](https://link.springer.com/article/10.1007/s40801-017-0108-7). Peterson, C. & Gustafsson, M. Drugs***---***Real World Outcomes (2017) 4: 97.

[Examining the Quality of Medicines at Kenyan Healthcare Facilities: A Validation of an Alternative Post-Market Surveillance Model That Uses Standardized Patients](https://link.springer.com/article/10.1007/s40801-016-0100-7). Wafula, F., Dolinger, A., Daniels, B. et al. Drugs***---***Real World Outcomes (2017) 4: 53.

[HER2-Positive Metastatic Breast Cancer Patients Receiving Pertuzumab in a Community Oncology Practice Setting: Treatment Patterns and Outcomes](https://link.springer.com/article/10.1007/s40801-016-0102-5). Robert, N.J., Goertz, HP., Chopra, P. et al. Drugs - Real World Outcomes (2017) 4: 1.

[Risk of Hip Fracture in Older People Using Selective Serotonin Reuptake Inhibitors and Other Psychoactive Medicines Concurrently: A Matched Case--Control Study in Australia](https://link.springer.com/article/10.1007/s40801-017-0107-8). Leach, M.J., Pratt, N.L. & Roughead, E.E. Drugs***---***Real World Outcomes (2017) 4: 87.

[Treatment Satisfaction During Sublingual Immunotherapy with a Five-Grass Pollen Tablet for Allergic Rhinoconjunctivitis: A Prospective, Non-Interventional Study](https://link.springer.com/article/10.1007/s40801-017-0109-6). Schäfer, U., Kienle-Gogolok, A., Hadler, M. et al. Drugs***---***Real World Outcomes (2017) 4: 109.

[Characterization of Stevens--Johnson Syndrome and Toxic Epidermal Necrolysis Among Patients Admitted to Kenyatta National Hospital: A Retrospective Cross-Sectional Study](https://link.springer.com/article/10.1007/s40801-017-0105-x). Irungu, K., Nyamu, D. & Opanga, S. Drugs***---***Real World Outcomes (2017) 4: 79.

[Pharmacist's Comprehensive Geriatric Assessment: Introduction and Evaluation at Elderly Patient Admission](https://link.springer.com/article/10.1007/s40801-016-0098-x). Rhalimi, F., Rhalimi, M. & Rauss, A. Drugs***---***Real World Outcomes (2017) 4: 43.

[Non-Steroidal Anti-Inflammatory Drug Use and the Risk of Acute Myocardial Infarction in the General German Population: A Nested Case--Control Study](https://link.springer.com/article/10.1007/s40801-017-0113-x). Thöne, K., Kollhorst, B. & Schink, T. Drugs***---***Real World Outcomes (2017) 4: 127.

[Spontaneously Reported Adverse Reactions for Herbal Medicinal Products and Natural Remedies in Sweden 2007--15: Report from the Medical Products Agency](https://link.springer.com/article/10.1007/s40801-017-0104-y). Svedlund, E., Larsson, M. & Hägerkvist, R. Drugs***---***Real World Outcomes (2017) 4: 119.

[Tolerability of an Immunologically Enhanced Subcutaneous Immunotherapy Preparation in Patients Treated with Concomitant Allergy Immunotherapy: A Non-Interventional Observational Study](https://link.springer.com/article/10.1007/s40801-016-0103-4). Reiber, R., Wolf, H., Schnitker, J. et al. Drugs***---***Real World Outcomes (2017) 4: 65.

Other journals in the Adis Premier Journals Portfolio (<http://www.springer.com/gp/adis>) continue to prosper, and this year has seen the successful launch of *PharmacoEconomics---Open*, the newest journal in the portfolio. The journal has published a full volume of 30 articles in its first year, plus many more online first. Following in the steps of Adis' flagship subscription journal in the field, *PharmacoEconomics*, the new open-access journal focuses on cost and health outcomes associated with drugs, devices and other healthcare interventions.

We thank the authors who have contributed articles to *Drugs---Real World Outcomes* over the course of 2017. The skill and dedication of all authors are critical to the continued publication of the journal. The quality of published articles is also testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal's content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for *Drugs---Real World Outcomes* in the last 12 months:

*Sura Alwan*, Canada

*Mulugeta Tarekegn Angamo*, Australia

*Alejandro Arana*, Spain

*Joanne Barnes*, New Zealand

*Claudio Borghi*, Italy

*Rhiannon Braund*, New Zealand

*Shawn Bugden*, Canada

*Xiaoyan Cai*, China

*Ryan M. Carnahan*, USA

*Jongwha Chang*, USA

*Hsin*-*Hua Chen*, Taiwan, Republic of China

*Lita Chew*, Singapore

*Wen*-*Hung Chung*, Taiwan, Republic of China

*Al Cozzi*-*Lepri*, UK

*Alexander N. O. Dodoo*, Ghana

*Mahyar Etminan*, Canada

*Mercé Falip*, Spain

*José Carlos García Robaina*, Spain

*Danijela Gnjidic*, Australia

*Bertrand Guignard*, Switzerland

*Maria Gustafsson*, Sweden

*Richard A. Hansen*, USA

*Amany Hassan*, USA

*Lina Hellström*, Sweden

*Maria Teresa F. Herdeiro*, Portugal

*Daniel Horton*, USA

*Consuelo Huerta*, Spain

*Virva Hyttinen*, Finland

*Cristoforo Incorvaia*, Italy

*Kathrin Jobski*, Germany

*Lauren E. Kelly*, Canada

*Ronald Kiguba*, Uganda

*Karel Kostev*, Germany

*Shih*-*Wei Lai*, Taiwan, Republic of China

*Michele P. Lambert*, USA

*Marie*-*Laure Laroche*, France

*Myeong Soo Lee*, Republic of Korea

*Shing*-*Hwa Liu*, Taiwan, Republic of China

*Ersilia Lucenteforte*, Italy

*Yoann Madec*, France

*T. Joseph Mattingly II*, USA

*Ann W. McMahon*, USA

*Peter Mol*, the Netherlands

*Michael Mosier*, USA

*Yasuyuki Okumura*, Japan

*Sten Olsson*, Sweden

*Mei*-*Sing Ong*, USA

*Antoine Pariente*, France

*Carole Parsons*, UK

*Rodrigo Ramos*-*Zúñiga*, Mexico

*Albert Roger*, Spain

*Leyla Sahin*, USA

*John D. Seeger*, USA

*Sabine Seisling*, the Netherlands

*Jim Slattery*, UK

*Patrick Souverein*, the Netherlands

*Michael A. Steinman*, USA

*Wenqing Su*, USA

*Rolf Teschke*, Germany

*Judy van Stralen*, Canada

*Bastiaan Venhuis*, the Netherlands

*Ami Vyas*, USA

*Shirley Wang*, USA

*Chi*-*Chuan Wang*, Taiwan, Republic of China

*Stuart J. Warden*, USA

*Rei Watanabe*, Japan

*Juanita Westbury*, Australia

*Saranrat Wittayanukorn*, USA

*Juan Yang*, China

*Jinquan Yu*, China

In addition, we would like to thank the members of the journal's Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:

*Darrell R. Abernethy*, USA

*G. Caleb Alexander*, USA

*Ariel Beresniak*, Switzerland

*Howard Birnbaum*, USA

*Juliana Bottomley*, UK

*Petra Denig*, the Netherlands

*Jack E. Fincham*, USA

*Brian Godman*, Sweden

*David Goldsmith*, USA

*Sudeep Karve*, USA

*Noam Y. Kirson*, USA

*Chris Kozma*, USA

*Tamar Lasky*, USA

*Arduino A. Mangoni*, Australia

*Suzana Mimica*-*Matanovic*, Croatia

*Ankita Modi*, USA

*Barbara Rinaldi*, Italy

*Janet K. Sluggett*, Australia

*Keith A. Swanson*, USA

*John E. Ware Jr*, USA

*Quan Zou*, USA

We do hope that you have found the articles published throughout the year in *Drugs---Real World Outcomes* to be interesting and informative. The editorial schedule for 2018 is well under way, and we are looking forward to bringing you many high-quality and authoritative articles over the coming year.

With best wishes from Dene Peters (Editor) and Kathy Fraser (Deputy Editor).
